Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features.
CLL
Hairy cell leukemia
bone marrow
flow cytometry
immunohistochemistry
Journal
Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
pubmed:
7
8
2020
medline:
28
4
2021
entrez:
7
8
2020
Statut:
ppublish
Résumé
Simultaneous occurrence of hairy cell leukemia (HCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (termed CLL) is very rare. Clinical characteristics, pathology and management of these cases have not been well described. We present six patients with CLL and HCL or HCL variant (HCL-v). Of six patients, three were initially diagnosed with CLL and later developed concurrent HCL. Two patients had concurrent HCL or HCL-v and CLL at initial diagnosis. One had HCL first, followed by concurrent CLL. Polymerase chain reaction analysis demonstrated B-cell clonality in all cases, with two distinct clonal populations in four cases, and three clonal populations in one case. Five patients were treated with a combination of a purine analog such as fludarabine, cladribine, and pentostastin with either rituximab or ibrutinib, while one received dabrefenib and trametinib. All patients achieved a durable response to either CLL or HCL-directed therapy with reduction or ablation of coexisting B-cell clones.
Identifiants
pubmed: 32755330
doi: 10.1080/10428194.2020.1797007
pmc: PMC8926167
mid: NIHMS1778736
doi:
Substances chimiques
Cladribine
47M74X9YT5
Rituximab
4F4X42SYQ6
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
3177-3187Subventions
Organisme : Intramural NIH HHS
ID : ZIA BC010301
Pays : United States
Références
Mod Pathol. 2018 Nov;31(11):1717-1732
pubmed: 29955146
Leukemia. 2002 Aug;16(8):1454-9
pubmed: 12145685
Leukemia. 2016 Apr;30(4):929-36
pubmed: 26639181
Blood. 2015 Feb 19;125(8):1207-16
pubmed: 25480661
Blood. 2019 Mar 14;133(11):1264
pubmed: 30872271
Leuk Res. 2013 Apr;37(4):401-409
pubmed: 23347903
Br J Haematol. 2016 Jul;174(2):329-31
pubmed: 26455504
Am J Hematol. 2018 Dec;93(12):1568-1569
pubmed: 30152528
Eur J Haematol. 2001 Nov-Dec;67(5-6):322-7
pubmed: 11872081
Am J Hematol. 2004 Feb;75(2):107-9
pubmed: 14755378
J Exp Med. 2004 Jan 5;199(1):59-68
pubmed: 14707115
Am J Hematol. 2019 Dec;94(12):1413-1422
pubmed: 31591741
Am J Clin Pathol. 2012 Apr;137(4):647-59
pubmed: 22431543
J Natl Cancer Inst. 2007 Feb 7;99(3):215-22
pubmed: 17284716
Am J Surg Pathol. 2007 Oct;31(10):1605-14
pubmed: 17895764
Cytometry B Clin Cytom. 2018 Jan;94(1):148-150
pubmed: 28109040
J BUON. 2016 Jul-Aug;21(4):1027-1029
pubmed: 27685932
Clin Case Rep. 2018 Feb 13;6(4):753-755
pubmed: 29636954
Hum Pathol. 1994 Dec;25(12):1276-82
pubmed: 8001921
Int J Surg Pathol. 2011 Jun;19(3):377-81
pubmed: 19372083
Am J Hematol. 2017 Dec;92(12):1398-1399
pubmed: 27727469
Blood Res. 2018 Jun;53(2):160-163
pubmed: 29963523
Leuk Lymphoma. 1998 Jun;30(1-2):203-9
pubmed: 9669692
Am J Case Rep. 2020 Mar 09;21:e921131
pubmed: 32150530
Leukemia. 2003 Dec;17(12):2257-317
pubmed: 14671650
Best Pract Res Clin Haematol. 2015 Dec;28(4):253-63
pubmed: 26614904
Am J Surg Pathol. 2010 Oct;34(10):1425-35
pubmed: 20871216
N Engl J Med. 2011 Jun 16;364(24):2305-15
pubmed: 21663470
Hum Pathol. 2013 Jan;44(1):110-21
pubmed: 22944294
CA Cancer J Clin. 2016 Nov 12;66(6):443-459
pubmed: 27618563
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Case Rep Hematol. 2017;2017:2861596
pubmed: 29387498
Case Rep Oncol. 2020 Feb 13;13(1):120-129
pubmed: 32231533
Front Neurol. 2018 Apr 24;9:267
pubmed: 29740389
Am J Clin Pathol. 2020 Feb 8;153(3):322-327
pubmed: 31665200
Int J Surg Pathol. 2018 Apr;26(2):135-144
pubmed: 29069998
Am J Surg Pathol. 2013 Feb;37(2):272-81
pubmed: 23282972
J Clin Pathol. 1992 Sep;45(9):770-5
pubmed: 1401205
Front Oncol. 2017 Jan 09;6:270
pubmed: 28119853